U.S., June 12 -- ClinicalTrials.gov registry received information related to the study (NCT07015268) titled 'A Clinical Study of KLH-2109 in Patients With Endometriosis' on June 03.
Brief Summary: To verify the non-inferiority of KLH-2109 to leuprorelin acetate in a double-blind manner in terms of efficacy in endometriosis patients with pelvic pain.
Study Start Date: June, 2025
Study Type: INTERVENTIONAL
Condition:
Endometriosis
Intervention:
DRUG: KLH-2109
- KLH-2109 tablet: Oral administration
- Leuprorelin acetate placebo: Subcutaneous administration
DRUG: Leuprorelin acetate
- KLH-2109 placebo tablet: Oral administration
- Leuprorelin acetate: Subcutaneous administration
Recruitment Status: RECRUITING
Sponsor: Kissei Pharm...